The Pennant Group (NASDAQ:PNTG) Announces FY 2026 Earnings Guidance

The Pennant Group (NASDAQ:PNTG) updated its FY 2026 earnings guidance on Friday. The company provided EPS guidance of 1.340-1.410 for the period, compared to the consensus EPS estimate of 1.360. The company issued revenue guidance of $1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on PNTG shares. Wall Street Zen cut The Pennant Group from a “buy” rating to a “hold” rating in a research report on Saturday. Oppenheimer upped their target price on The Pennant Group from $47.00 to $50.00 and gave the stock an “outperform” rating in a research report on Thursday. Truist Financial upped their target price on The Pennant Group from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada raised their price target on The Pennant Group from $44.00 to $48.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Weiss Ratings upgraded The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, August 19th. Six equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, The Pennant Group has a consensus rating of “Moderate Buy” and a consensus target price of $48.00.

The Pennant Group Stock Performance

PNTG stock opened at $36.36 on Friday. The company has a quick ratio of 1.20, a current ratio of 1.18 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of 36.73, a P/E/G ratio of 2.37 and a beta of 1.33. The Pennant Group has a 12 month low of $23.50 and a 12 month high of $44.24. The firm has a 50 day moving average of $40.16 and a two-hundred day moving average of $35.70.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.01). The business had revenue of $302.25 million for the quarter, compared to analyst estimates of $299.34 million. The Pennant Group had a return on equity of 10.23% and a net margin of 3.05%. As a group, equities analysts anticipate that The Pennant Group will post 1.18 EPS for the current fiscal year.

Key Headlines Impacting The Pennant Group

Here are the key news stories impacting The Pennant Group this week:

• Positive Sentiment: RBC raised its price target to $48 from $44 and maintained an Outperform rating. RBC Raises Price Target on Pennant Group
• Positive Sentiment: Oppenheimer also lifted its target, to $50 from $47, and reiterated an Outperform rating—suggesting continued analyst confidence in the company’s prospects.
• Positive Sentiment: Q3 coverage said Pennant beat earnings and sales expectations, a supportive signal for demand and financial performance. Pennant Group Earnings Beat Pennant Group Beats Q3 Sales Expectations
• Neutral Sentiment: For FY 2026, Pennant guided to EPS of $1.34–$1.41, straddling the $1.36 consensus, and revenue of $1.2 billion, in line with expectations. The range offers limited upside versus consensus, while its lower end is below it.
• Negative Sentiment: A Q3 analysis highlighted margin pressure and integration challenges as risks to the outlook. These concerns may temper the impact of the earnings beat and analyst target increases. Q3 Deep Dive: Margin Pressure and Integration Challenges

The Pennant Group Company Profile

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.

Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.